Teladoc Health, Inc. (NYSE: TDOC)

The Covid-19 pandemic has placed extraordinary pressure on the nation’s healthcare system, and that, in turn has triggered explosive growth in telemedicine and virtual health options.

Teladoc Health, Inc. (NYSE: TDOC) has seen its trailing 12-month revenue grow 85% year-over-year to $716 million. And its paid membership base has expanded by 92% over its level in the second quarter of 2019.

The company’s revenue model includes both subscription fees and copays for its services, and boasts more than 70 million members in the United States.

According to the company, “the demand for virtual care visits has accelerated as several health plans have waived consumer cost sharing and public health officials at all levels of government have encouraged the public to take advantage of virtual care services. These actions have driven many people to use telemedicine for the first time, with more than half of all the Teladoc Health visits this month being from first time users.”

The company has seen already seen a coronavirus-related surge in share price, but it is in solid financial shape, has made a handful of significant recent acquisitions and could enjoy a much longer run in the months ahead.

In addition, the company is projecting revenue growth of at least 30% next year, thanks in part to its ongoing merger with Livongo Health (Nasdaq: LVGO).